Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon Riddler

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
AIDS Research and Human Retroviruses|August 24, 2004
Suction-assisted lipectomy for lipodystrophyNancy Connolly, Ernest Manders, Sharon Riddler
Cancer Research|October 16, 2003
Comparison of the selective estrogen receptor modulator arzoxifene (LY353381) with tamoxifen on tumor growth and biomarker expression in an MCF-7 human breast cancer xenograft modelSimone Detre, Sharon Riddler, Janine Salter, et al.
AIDS (London, England)|August 11, 2007
Levels of antigen processing machinery components in dendritic cells generated for vaccination of HIV-1+ subjectsNancy Connolly, Sharon Riddler, Joanna Stanson, et al.
AIDS (London, England)|April 20, 2004
Changes in adherence to highly active antiretroviral therapy medications in the Multicenter AIDS Cohort StudyCynthia A Kleeberger, Jennifer Buechner, Frank Palella, et al.
Plos One|January 26, 2018
Lower pre-ART intra-participant HIV-1 pol diversity may not be associated with virologic failure in adultsMary F Kearney, Jonathan Spindler, Ann Wiegand, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 15, 2013
Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiationPhilip M Grant, Douglas Kitch, Grace A McComsey, et al.
British Journal of Clinical Pharmacology|July 9, 2021
Multicompartmental pharmacokinetic evaluation of long-acting cabotegravir in healthy adults for HIV preexposure prophylaxisJafar Sadik Shaik, Ethel D Weld, Stacey Edick, et al.
International Journal of STD & AIDS|March 23, 2021
Likely clinical depression and HIV-related decline in antiretroviral therapy untreated women who seroconverted during participation in microbicide trials in sub-Saharan AfricaChristine T Rael, Sarah Roberts, Mbolaji Ibitoye, et al.
Antiviral Therapy|October 2, 2003
A controlled Phase II trial assessing three doses of enfuvirtide (T-20) in combination with abacavir, amprenavir, ritonavir and efavirenz in non-nucleoside reverse transcriptase inhibitor-naive HIV-infected adultsJacob P Lalezari, Edwin DeJesus, Donald W Northfelt, et al.
The Journal of Infectious Diseases|February 28, 2002
Safety and antiviral activity at 48 weeks of lopinavir/ritonavir plus nevirapine and 2 nucleoside reverse-transcriptase inhibitors in human immunodeficiency virus type 1-infected protease inhibitor-experienced patientsConstance A Benson, Steven G Deeks, Scott C Brun, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
AIDS Research and Human Retroviruses|August 24, 2004
Suction-assisted lipectomy for lipodystrophyNancy Connolly, Ernest Manders, Sharon Riddler
Cancer Research|October 16, 2003
Comparison of the selective estrogen receptor modulator arzoxifene (LY353381) with tamoxifen on tumor growth and biomarker expression in an MCF-7 human breast cancer xenograft modelSimone Detre, Sharon Riddler, Janine Salter, et al.
AIDS (London, England)|August 11, 2007
Levels of antigen processing machinery components in dendritic cells generated for vaccination of HIV-1+ subjectsNancy Connolly, Sharon Riddler, Joanna Stanson, et al.
AIDS (London, England)|April 20, 2004
Changes in adherence to highly active antiretroviral therapy medications in the Multicenter AIDS Cohort StudyCynthia A Kleeberger, Jennifer Buechner, Frank Palella, et al.
Plos One|January 26, 2018
Lower pre-ART intra-participant HIV-1 pol diversity may not be associated with virologic failure in adultsMary F Kearney, Jonathan Spindler, Ann Wiegand, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 15, 2013
Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiationPhilip M Grant, Douglas Kitch, Grace A McComsey, et al.
British Journal of Clinical Pharmacology|July 9, 2021
Multicompartmental pharmacokinetic evaluation of long-acting cabotegravir in healthy adults for HIV preexposure prophylaxisJafar Sadik Shaik, Ethel D Weld, Stacey Edick, et al.
International Journal of STD & AIDS|March 23, 2021
Likely clinical depression and HIV-related decline in antiretroviral therapy untreated women who seroconverted during participation in microbicide trials in sub-Saharan AfricaChristine T Rael, Sarah Roberts, Mbolaji Ibitoye, et al.
Antiviral Therapy|October 2, 2003
A controlled Phase II trial assessing three doses of enfuvirtide (T-20) in combination with abacavir, amprenavir, ritonavir and efavirenz in non-nucleoside reverse transcriptase inhibitor-naive HIV-infected adultsJacob P Lalezari, Edwin DeJesus, Donald W Northfelt, et al.
The Journal of Infectious Diseases|February 28, 2002
Safety and antiviral activity at 48 weeks of lopinavir/ritonavir plus nevirapine and 2 nucleoside reverse-transcriptase inhibitors in human immunodeficiency virus type 1-infected protease inhibitor-experienced patientsConstance A Benson, Steven G Deeks, Scott C Brun, et al.
Pageof 2